secwatch.observer — SEC 8-K summary
======================================

Issuer:     CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
CIK:        0001035422
Form:       8-K
Filed at:   2026-08-12T11:30:23+00:00
Accession:  0001171520-26-000225
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CTT Pharma gets U.S. patent for nicotine, vitamin, caffeine delivery tech
-------------------------------------------------------------------------

- USPTO approved continuation-in-part patent for micelle delivery technology, effective Aug 11, 2026.
- Patent covers nicotine, vitamins, and caffeine; enables dissolvable strips, gum, pouches, lozenges, and dissolving tablets.
- Company states it will continue strengthening its patent portfolio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035422/000117152026000225/0001171520-26-000225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035422/000117152026000225/eps12766_ctth.htm
  HTML page:      https://secwatch.observer/filing/0001171520-26-000225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer